By Rising Star Stocks 
The number is hard to say out loud without stopping to think about it. Oracle (ORCL) closed fiscal 2026 with $638 billion in remaining performance obligations — contracted future revenue that has already been signed and is waiting to be delivered. That backlog grew 363% year over year, driven by massive AI infrastructure deals, including a widely reported arrangement with OpenAI.
The stock, as of this week, is down roughly 62% from its September 2025 peak. That slide wiped nearly $600 billion in market value off the company. The gap between what the business has contracted and what the stock is pricing is one of the widest in the entire AI trade right now.
So what exactly is happening here?
The Numbers That Created the Gap
Oracle’s Q4 fiscal 2026 results beat on both revenue and earnings. Revenue came in at $19.18 billion, up 21% year over year. Non-GAAP EPS hit $2.11, above the $1.96 estimate. Oracle Cloud Infrastructure revenue grew 93% to $5.8 billion. The fastest-growing business inside Oracle, the Multicloud AI Database unit, expanded rapidly year over year.
By any operating measure, the business is accelerating. But the market sold the stock again after earnings.
The reason is cash. Oracle reported operating cash flow of $32.0 billion for fiscal 2026, but free cash flow showed a loss of $23.7 billion as it ramped up cloud infrastructure investment. To fund that build-out, Oracle has leaned on external financing, and the company has discussed raising roughly $40 billion more in debt and equity. The S&P downgraded its credit rating to BBB-, one notch above junk, earlier this month.
That is the trade-off in plain terms: a $638 billion backlog being built while free cash flow is deeply negative as the capacity comes online. Investors who believe the cash flows will eventually normalize are looking at what they think is a generational discount. Investors who don’t are looking at a highly leveraged infrastructure bet concentrated in OpenAI — itself an organization facing competitive and strategic pressure.
The Concentration Risk Nobody Is Fully Modeling
This is where it gets interesting. A widely reported OpenAI arrangement with Oracle has been described as roughly a $300 billion, multi-year compute agreement, and some investors continue to question whether OpenAI can meet the terms of that kind of commitment. OpenAI’s IPO has been delayed. Its competitive positioning is being challenged by open-source models and by hyperscalers building their own AI capabilities internally.
At the same time, Oracle argues — and the data supports — that its backlog is broader than one client.
Slight tangent, but it matters: Oracle’s market cap as of this week is roughly $382 billion based on a recent close near $132, while its contracted future revenue sits at $638 billion. That is a backlog about 1.7 times the size of the company’s equity value. It is an unusual ratio in any industry.
What Analysts Are Actually Saying
Piper Sandler raised its target to $225, citing strong backlog growth and confidence in margin protection. Mizuho maintained Outperform with a $320 target. The analyst community is nearly unanimous in its view. The stock is not moving because cash flow execution — not demand — is the constraint the market is pricing.
The Options Picture
Oracle’s 30-day implied volatility sits near 63, compared to a 52-week range of 31 to 85. That is elevated but not extreme. Call put ratio recently ran at 2.2 calls to 1 put, with a focus on late July weekly calls — suggesting the speculative lean has turned constructive at the current price level.
The call-heavy open interest in late July expirations suggests the market is starting to lean toward a mean-reversion move. The next formal earnings date has not been announced; market calendars estimate it will fall around September 9–10.
Trade Framework
Bull case: For traders who believe the $130 level holds and that AI infrastructure build-out execution is manageable, a defined-risk bull call spread in the August or September expiration targeting a move toward $160 to $180 captures the mean-reversion thesis while limiting downside. The 90%-plus analyst buy consensus and a price target more than double the current level are the backdrop.
Bear case: If OpenAI’s financial position deteriorates further, or if Oracle’s Q1 FY2027 guidance (expected around early September) reveals further cash flow deterioration, a bear put spread targeting a flush toward $115 to $120 defines the downside. The credit downgrade and equity dilution risk are the fundamental triggers to watch.
Neutral case: An iron condor using the August expiration, selling the $120 put and $150 call, captures elevated IV in a range-bound environment if neither catalyst fires cleanly before September.
The core question is not whether Oracle has demand. It clearly does. The question is whether a multi-year revenue recognition schedule and heavy infrastructure investment are manageable at the scale Oracle is attempting. The stock says no. The backlog, the analyst consensus, and the options flow are starting to say yes. That divergence is where the trade lives.